Tumor differentially expressed 2 (TDE2), also known as Serinc2, was first identified in non‐small cell lung cancer (NSCLC) cells, and TDE2 expression was higher in NSCLC samples [18]. This evidence concerns the gene SERINC1 and non-small cell lung carcinoma.